NASDAQ
Grace Therapeutics, Inc. (GRCE) has a fcf yield of -54.08% as of Friday, May 29, 2026. This represents a 46.04% increase compared to its 12-month average of -100.23%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.